Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

Stephanie Link, Chief investment strategist, HightowerElanco Animal HealthELANBUYAug 30, 2024

Is up 17% in August. It's all about animal health, an enormous industry. They have a fine product pipeline, and all products' revenues have climbed from $350-400 million to $450 million. Cheap at 14x PE and 1x book.

$15.47

Stock price when the opinion was issued

$24.17

As of Jun 12, 2026. Market Open.

Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

BUY

Is impressed with their turnaround.

WEAK BUY

Spun off from Eli Lilly in 2018. Reported a mixed report today, including their pet business missing as guidance for the current quarter fell short. They will sell its Aqua business to Merck Animal Health, announced restructuring/job cuts and will increase cash flow conversions four times this year, which is a priority. This gives him some hope in the name.